“Biological Evaluation of 2,3-Dioxoindolin-N-Phenylacetamide Derivatives As Potent CDC25B and PTP1B Phosphatase Inhibitors”. 2020. Brazilian Journal of Pharmaceutical Sciences 56 (dezembro): e00222. https://doi.org/10.1590/s2175-97902019000400222.